BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 1333745)

  • 1. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
    Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Ann N Y Acad Sci; 1998 May; 841():530-3. PubMed ID: 9668288
    [No Abstract]   [Full Text] [Related]  

  • 8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
    Cui LY; Li YF; Li YH; Zhang JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
    Suzuki S
    Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis and autoantibodies.
    Nishitani H
    Jpn J Med; 1988 May; 27(2):228-9. PubMed ID: 3418994
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmunity against the ryanodine receptor in myasthenia gravis.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
    Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
    [No Abstract]   [Full Text] [Related]  

  • 15. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
    Iwasa K; Asaka T; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):655-63. PubMed ID: 9627474
    [No Abstract]   [Full Text] [Related]  

  • 17. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F; Skeie GO; Aarli JA; Gilhus NE
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
    Shelton GD; Skeie GO; Kass PH; Aarli JA
    Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.
    Skeie GO; Mygland A; Treves S; Gilhus NE; Aarli JA; Zorzato F
    Muscle Nerve; 2003 Jan; 27(1):81-9. PubMed ID: 12508299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
    Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.